Use of Cardiopulmonary Stress Testing for Patients With Unexplained Dyspnea Post-Coronavirus Disease
Donna M Mancini, Danielle L Brunjes, Anuradha Lala, Maria Giovanna Trivieri, Johanna P Contreras, Benjamin H Natelson, Donna M Mancini, Danielle L Brunjes, Anuradha Lala, Maria Giovanna Trivieri, Johanna P Contreras, Benjamin H Natelson
Abstract
Objectives: The authors used cardiopulmonary exercise testing (CPET) to define unexplained dyspnea in patients with post-acute sequelae of severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) infection (PASC). We assessed participants for criteria to diagnose myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS).
Background: Approximately 20% of patients who recover from coronavirus disease (COVID) remain symptomatic. This syndrome is named PASC. Its etiology is unclear. Dyspnea is a frequent symptom.
Methods: The authors performed CPET and symptom assessment for ME/CFS in 41 patients with PASC 8.9 ± 3.3 months after COVID. All patients had normal pulmonary function tests, chest X-ray, and chest computed tomography scans. Peak oxygen consumption (peak VO2), slope of minute ventilation to CO2 production (VE/VCO2 slope), and end tidal pressure of CO2 (PetCO2) were measured. Ventilatory patterns were reviewed with dysfunctional breathing defined as rapid erratic breathing.
Results: Eighteen men and 23 women (average age: 45 ± 13 years) were studied. Left ventricular ejection fraction was 59% ± 9%. Peak VO2 averaged 20.3 ± 7 mL/kg/min (77% ± 21% predicted VO2). VE/VCO2 slope was 30 ± 7. PetCO2 at rest was 33.5 ± 4.5 mm Hg. Twenty-four patients (58.5%) had a peak VO2 <80% predicted. All patients with peak VO2 <80% had a circulatory limitation to exercise. Fifteen of 17 patients with normal peak VO2 had ventilatory abnormalities including peak respiratory rate >55 (n = 3) or dysfunctional breathing (n = 12). For the whole cohort, 88% of patients (n = 36) had ventilatory abnormalities with dysfunctional breathing (n = 26), increased VE/VCO2 (n = 17), and/or hypocapnia PetCO2 <35 (n = 25). Nineteen patients (46%) met criteria for ME/CFS.
Conclusions: Circulatory impairment, abnormal ventilatory pattern, and ME/CFS are common in patients with PASC. The dysfunctional breathing, resting hypocapnia, and ME/CFS may contribute to symptoms. CPET is a valuable tool to assess these patients.
Keywords: cardiopulmonary exercise testing; dyspnea; post-acute sequelae of severe acute respiratory syndrome coronavirus 2 infection.
Conflict of interest statement
Funding Support and Author Disclosures The authors have reported that they have no relationships relevant to the contents of this paper to disclose.
Copyright © 2021 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.
Figures
References
- Wiersinga W.J., Rhodes A., Cheng A.C., et al. Pathophysiology, transmission, diagnosis, and treatment of Coronavirus Disease 2019 (COVID-19): a review. JAMA. 2020;324:782–793.
- Zheng Y.Y., Ma Y.T., Zhang J.Y., Xie X. COVID-19 and the cardiovascular system. Nat Rev Cardiol. 2020:259–260.
- Zhao Y.M., Shang Y.M., Song W.B., et al. Follow-up study of the pulmonary function and related physiological characteristics of COVID-19 survivors three months after recovery. EClinicalMedicine. 2020:100463.
- Goërtz Y.M.J., Van Herck M., Delbressine J., et al. Persistent symptoms 3 months after a SARS-CoV-2 infection: the post-COVID-19 syndrome? ERJ Open Res. 2020;6 .
- Carfì A., Bernabei R., Landi F. Gemelli Against COVID-19 Post-Acute Care Study Group. Persistent symptoms in patients after acute COVID-19. JAMA. 2020;324:603–605.
- Rajpal S., Tong M., Borchers J., et al. Cardiovascular magnetic resonance findings in competitive athletes recovering from CoVid 19 infection. JAMA Cardiol. 2021;6:116–118.
- Moldofsky H., Patcai J. Chronic widespread musculoskeletal pain, fatigue, depression and sleep disordered breathing in chronic post SARS syndrome; a case controlled study. BMC Neurol. 2011;11:37.
- Maron B., Cockrill B., Waxman A., Systrom D. The invasive cardiopulmonary exercise test. Circulation. 2013;127:1157–1164.
- Oldham W., Lewis G., Opotowsky A., Waxman A., Systrom D. Unexplained exertional dyspnea caused by low ventricular filling pressures: results from clinical invasive cardiopulmonary exercise testing. Pulm Circ. 2016;6:55–62.
- Montiejunaite J., Balagny P., Arnoult F., et al. Hyperventilation: a possible explanation for long-lasting exercise intolerance in mild COVID-19 survivors. Front Physiol. 2021;11:614590.
- Clavario P., De Marzo V., Lotti R., et al. Assessment of functional capacity with cardiopulmonary exercise testing in non-severe COVID-19 patients at three months follow-up. medRxiv. 2020;7(3):00205–2021. .
- Raman B., Cassar M., Tunnicliffe E., et al. Medium term effects of SARS-CoV-2 infection on multiple vital organs, exercise capacity, cognition, quality of life and mental health, post-hospital discharge. EClinical Medicine. 2021;31:100683.
- Fukuda K., Straus S.E., Hickie I., Sharpe M.C., Dobbins J.G., Komaroff A. The chronic fatigue syndrome: a comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group. Ann Intern Med. 1994;121:953–959.
- Baba R., Nagashima M., Goto M., et al. Oxygen uptake efficiency slope: a new index of cardiorespiratory functional reserve derived from the relation between oxygen uptake and minute ventilation during incremental exercise. J Am Coll Cardiol. 1996;28:1567–1572.
- Ionescu M.F., Mani-Babu S., Degani-Costa L.H., et al. Cardiopulmonary exercise testing in the assessment of dysfunctional breathing. Front Physiol. 2021;11:620955.
- Wasserman K., Hansen J., Sue D., Stringer W., Whipp B., editors. Principles of Exercise Testing and Interpretation. Lippincott, Williams and Wilkins; Philadelphia, PA: 2005. Chapter 8. Principles of interpretation: a flowchart approach; pp. 183–196.
- Higginbotham M.B., Morris K.G., Williams R.S., McHale P.A., Coleman R.E., Cobb F.R. Regulation of stroke volume during submaximal and maximal upright exercise in normal man. Circ Res. 1986;58:281–291.
- Sullivan M., Higginbotham M., Cobb F. Increased exercise ventilation in patients with chronic heart failure: intact ventilatory control despite hemodynamic and pulmonary abnormalities. Circulation. 1988;77:552–559.
- Hayano J., Yasuma F., Okada A., Mukai S., Fujinami T. Respiratory sinus arrhythmia. A phenomenon improving pulmonary gas exchange and circulatory efficiency. Circulation. 1996;94:842–847.
- Bokov P., Fiamma M.N., Chevalier-Bidaud B., et al. Increased ventilatory variability and complexity in patients with hyperventilation disorder. J Appl Physiol. 2016;120:1165–1172.
- Brat K., Stastna N., Merta Z., Olson L.J., Johnson B.D., Cundrle I., Jr. Cardiopulmonary exercise testing for identification of patients with hyperventilation syndrome. PLoS One. 2019;14:e0215997.
- Thomas M., McKinley R.K., Freeman E., Foy C., Prodger P., Price D. Breathing retraining for dysfunctional breathing in asthma: a randomized controlled trial. Thorax. 2003;58:110–115.
- Killian K.J., Jones N. Respiratory muscles and dyspnea. Clin Chest Med. 1988;9:237–248.
- Lavietes M.H., Natelson B.H., Cordero D.L., Ellis S.P., Tapp W.N. Does the stressed patient with chronic fatigue syndrome hyperventilate? Int J Behav Med. 1996;3:70–83.
- Hodges L.D., Nielsen T., Baken D. Physiological measures in participants with chronic fatigue syndrome, multiple sclerosis and healthy controls following repeated exercise: a pilot study. Clin Physiol Funct Imaging. 2018;38:639–644.
Source: PubMed